At present, faced with the challenge of China's entry into WTO, the national strategy of modernization of traditional Chinese medicine and the implementation of western development, the traditional Chinese medicine industry has been listed as a pillar industry in Guizhou Province, providing an unprecedented good environment and opportunity for the development of enterprises. To this end, the company will implement production management in strict accordance with GMP standards, take the road of modern development of traditional Chinese medicine, strengthen the training of human resources in enterprises, improve the marketing network system and improve the enterprise organization system. Faced with new forms and opportunities, Li San Pharmaceutical put forward the strategic idea of "striving for first-class enterprises, cultivating first-class talents and building first-class brands", insisting on breaking through oneself, constantly innovating and pursuing development, and repaying society and people's livelihood with first-class performance.
The company's development direction, development strategy and business objectives to be achieved in the near future and in the next 3-5 years:
Complete the first leap of the enterprise within three years. On the premise of maintaining the steady growth of existing products such as Li Qiang Tianma eucommia capsule, Naoliqing Capsule and Kaihoujian Spray, the varieties of traditional Chinese medicine soft capsules will be included in the core strategy, with Banlangen Soft Capsule, Hantaoye Soft Capsule, Wurenchun Soft Capsule and Wuji Baifeng Soft Capsule as the main products, which will drive the marketing operation of other traditional Chinese medicine products, complete the basic strategic platform of the company's traditional Chinese medicine innovation, and finally form a characteristic enterprise of traditional Chinese medicine soft capsules.